Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases
- Resource Type
- Source
- Kidney International, 100, 753-779
Kidney International, 100(4), 753-779. ELSEVIER SCIENCE INC
Kidney International, 100, 4, pp. 753-779
Kidney international 100(4), 753-779 (2021). doi:10.1016/j.kint.2021.05.015 - Subject
Adult medicine.medical_specialty Evidence-based practice Kidney Glomerulonephritis, Membranous anti-GBM Nephropathy IgA vasculitis Glomerulonephritis Focal segmental glomerulosclerosis systematic review Membranous nephropathy evidence-based medicine Humans complement Minimal change disease C3 Child Intensive care medicine glomerular diseases infection-related glomerulonephritis KDIGO lupus nephritis ANCA nephrotic syndrome business.industry MPGN Nephrosis, Lipoid membranous nephropathy AAV Glomerulonephritis, IGA IgA nephropathy Guideline medicine.disease FSGS minimal change disease Systematic review Nephrology Renal disorders Radboud Institute for Health Sciences [Radboudumc 11] business guideline - Language
- ISSN
- 0085-2538